Provided by Tiger Trade Technology Pte. Ltd.

uniQure NV

19.51
-0.2400-1.22%
Post-market: 19.580.0716+0.37%19:30 EST
Volume:1.85M
Turnover:36.36M
Market Cap:1.22B
PE:-4.49
High:20.00
Open:19.87
Low:19.34
Close:19.75
52wk High:71.50
52wk Low:7.76
Shares:62.29M
Float Shares:40.64M
Volume Ratio:0.70
T/O Rate:4.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3443
EPS(LYR):-4.9242
ROE:-165.27%
ROA:-13.89%
PB:5.31
PE(LYR):-3.96

Loading ...

Company Profile

Company Name:
uniQure NV
Exchange:
NASDAQ
Establishment Date:
1998
Employees:
209
Office Location:
Paasheuvelweg 25,Amsterdam,Noord-Holland,Netherlands
Zip Code:
1105 BP
Fax:
- -
Introduction:
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases. It offers HEMGENIX that has completed Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also develops AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease. In addition, it is developing AMT-162, which is in preclinical trial for the treatment of superoxide dismutase 1- amyotrophic lateral sclerosis; AMT-260 that is in preclinical trial to treat temporal lobe epilepsy; AMT-191, which is in preclinical trial for the treatment of fabry disease; AMT-161 that is in preclinical trial to treat amyotrophic lateral sclerosis caused by mutations; AMT-240, which is in preclinical trial to for the treatment of autosomal dominant Alzheimer's disease; and AMT-210 that is in preclinical trial to treat Parkinson's disease. The company was founded in 1998 and is headquartered in Amsterdam, the Netherlands.

Directors

Name
Position
Matthew Kapusta
Chief Executive Officer, Executive Director
David Meek
Non-Executive Director and Chair
Jack Kaye
Non-Executive Director
Jeremy Springhorn
Non-Executive Director
Leonard Post
Non-Executive Director
Madhavan Balachandran
Non-Executive Director
Rachelle Jacques
Non-Executive Director
Robert Gut
Non-Executive Director

Shareholders

Name
Position
Matthew Kapusta
Chief Executive Officer, Executive Director
Christian Klemt
Chief Financial Officer
Jeannette Potts
Chief Legal and Compliance Officer
Walid Abi Saab
Chief Medical Officer